The immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy is unknown. This prospective cohort study demonstrates that anti-SARS-CoV-2 spike antibody and neutralization titers are reduced in a subset of thoracic radiotherapy patients, possibly due to immunosuppressive conditions. Antibody testing may be useful to identify candidates for additional vaccine doses.
Keywords: COVID-19; Immunogenicity; Lung cancer; Radiotherapy; SARS-CoV-2; mRNA vaccine.
Copyright © 2021 Elsevier B.V. All rights reserved.